loadpatents
name:-0.01418399810791
name:-0.0095040798187256
name:-0.00041508674621582
McGarrity; Gerard J. Patent Filings

McGarrity; Gerard J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for McGarrity; Gerard J..The latest application filed is for "expression of apoai and variants thereof using spliceosome mediated rna trans-splicing".

Company Profile
0.9.9
  • McGarrity; Gerard J. - Gaithersburg MD US
  • McGarrity; Gerard J. - Gaithersburgh MD
  • McGarrity; Gerard J. - Wenonah NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
Grant 8,883,753 - Puttaraju , et al. November 11, 2
2014-11-11
Expression Of Apoai And Variants Thereof Using Spliceosome Mediated Rna Trans-splicing
App 20120046347 - Pattaraju; Madaiah ;   et al.
2012-02-23
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
Grant 8,053,232 - Puttaraju , et al. November 8, 2
2011-11-08
Compositions And Methods For Generation Of Pluripotent Stem Cells
App 20110263015 - D'Costa; Jenice G. ;   et al.
2011-10-27
Use Of Rna Trans-splicing For Antibody Gene Transfer And Antibody Polypeptide Production
App 20110244519 - McGarrity; Gerard J. ;   et al.
2011-10-06
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
Grant 7,968,334 - Puttaraju , et al. June 28, 2
2011-06-28
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
Grant 7,879,321 - McGarrity , et al. February 1, 2
2011-02-01
Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
Grant 7,871,795 - McGarrity , et al. January 18, 2
2011-01-18
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated RNA trans splicing
App 20060234247 - Puttaraju; Madaiah ;   et al.
2006-10-19
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
App 20060194317 - Puttaraju; Madaiah ;   et al.
2006-08-31
Expression of apoA-1 and variants thereof using spliceosome mediated RNA trans-splicing
App 20060177933 - Puttaraju; Madaiah ;   et al.
2006-08-10
Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
App 20060172381 - McGarrity; Gerard J. ;   et al.
2006-08-03
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
App 20060160182 - McGarrity; Gerard J. ;   et al.
2006-07-20
Use of spliceosome mediated RNA trans-splicing for immunotherapy
App 20060094110 - McGarrity; Gerard J. ;   et al.
2006-05-04
Delivery of therapeutic agents by gene therapy
Grant 6,669,935 - Oldfield , et al. December 30, 2
2003-12-30
Protease K resistant arginine deiminase, its method of preparation and its use as an anti-neoplastic agent
Grant 5,372,942 - McGarrity , et al. December 13, 1
1994-12-13
Rapid detection of mycoplasmas
Grant 4,855,227 - McGarrity , et al. August 8, 1
1989-08-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed